Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2011
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician, and IT and Engineering. The company provides flexible and permanent staffing solutions for specialty skills including laboratory/scientific, healthcare/nursing, physicians, and IT/engineering.
Key Financial Metrics
| Metric (in thousands) | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenues | $129,438 | $96,313 |
| Gross Profit | $43,154 | $30,823 |
| Gross Margin | 33.3% | 32.0% |
| Operating Income | $6,399 | $992 |
| Net Income | $3,164 | $(302) |
| Diluted EPS | $0.08 | $(0.01) |
| Cash from Operations | $5,778 | $6,412 |
| Cash and Equivalents (End of Period) | $15,821 | $30,250 |
| Total Debt (Current + Long-term) | $78,500 | $66,750 |
| Working Capital | $51,676 | $50,596 |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 34.4% year-over-year, driven by strong performance in the IT and Engineering segment (+67.9%) and Life Sciences segment (+43.0%).
- Profitability: The company returned to profitability, reporting net income of $3.2 million compared to a net loss of $0.3 million in the prior year. Operating income surged to $6.4 million from $1.0 million.
- Segment Performance:
- IT & Engineering: Revenue grew significantly due to a 54.8% increase in contract professionals on assignment.
- Life Sciences: Revenue growth attributed to increased demand and the impact of recent acquisitions (Cambridge, Sharpstream, Valesta).
- Physician: Revenue declined 12.5% due to a decrease in the number of physicians on assignment, attributed to economic conditions and reduced elective procedures.
- Acquisition Activity: The company acquired Valesta (a clinical research staffing provider) in February 2011 for an estimated $23.6 million ($16.8 million cash + earn-outs). This contributed $2.0 million in revenue and $0.1 million in net income for the quarter.
- Debt Structure: Total debt increased to $78.5 million. The company utilized its credit facility to fund the Valesta acquisition and refinanced existing debt.
Guidance, Outlook, and Risks
- Outlook: Management expects demand to strengthen in the second and third quarters, consistent with historical seasonality. The strategy focuses on organic growth and strategic acquisitions.
- Capital Expenditures: Estimated at approximately $7.4 million for 2011, largely driven by the build-out of a new corporate headquarters.
- Liquidity: Management believes working capital ($51.7 million), the credit facility, and operating cash flows are sufficient to fund operations and debt obligations for the next 12 months.
- Risks:
- Uncertain economic environment impacting client demand.
- Ability to attract and retain qualified staffing consultants.
- Foreign currency fluctuations (operations in Europe, Canada, Australia, NZ).
- Interest rate risk on variable rate debt (partially hedged via a $25 million interest rate swap).
- Contingencies: The company is partially self-insured for workers' compensation and medical malpractice, with reserves of approximately $10.6 million. There are no material pending legal proceedings expected to have an adverse effect.
Investor Verification Checklist
- Acquisition Integration: Verify the realization of synergies and revenue targets from the Valesta, Cambridge, and Sharpstream acquisitions.
- Debt Covenants: Confirm continued compliance with leverage ratios and fixed charge coverage ratios under the senior secured credit agreement.
- Seasonality Trends: Monitor Q2 and Q3 results to confirm the anticipated seasonal demand increase.
- Physician Segment Recovery: Assess whether the decline in the Physician segment stabilizes as economic conditions improve.
- Capital Expenditure Execution: Track the completion and cost efficiency of the new corporate headquarters build-out.